ERBB2 and cancer: Among different cancer types (ER+, HER2+ and TNBC) and other tumor-associated cells, we almost exclusively observed CLEC10A expression in the myeloid cell cluster (Fig. S5), preferentially in cDC2 and IL1B+ monocytes of which more than 40% of cells expressed CD301 (Fig. S6).